Sawai Pharmaceutical Company Limited This website provides information regarding Sawai Pharmaceutical Company Limited, a Japanese leading generic drug manufacturer. Wed, 05 Dec 2018 02:10:58 +0000 ja hourly 1 MHLW Approves New Indication for RISEDRONATE Tablets and DOBUTAMINE I.V. Infusion https://www.sawai.co.jp/en/file/2018/12/20181205-03.pdf Wed, 05 Dec 2018 11:10:58 +0000 MHLW Approves New Indication for LEVOFOLINATE I.V. Infusion https://www.sawai.co.jp/en/file/2018/11/20181121-02.pdf Wed, 21 Nov 2018 15:30:30 +0000 IR “Summary of Financial Results for the 1st Half of FY2018” https://www.sawai.co.jphttp://v4.eir-parts.net/v4Contents/View.aspx?template=ir_material_for_fiscal_ym&sid=55858&code=4555 Wed, 14 Nov 2018 15:12:20 +0000 IR “Financial Results for the 1st Half of FY 2018” https://www.sawai.co.jphttp://v4.eir-parts.net/v4Contents/View.aspx?template=ir_material_for_fiscal_ym&sid=55857&code=4555 Wed, 14 Nov 2018 15:11:22 +0000 Upsher-Smith Launches Generic Version of ONFI® (Clobazam), CIV In Tablet And Oral Suspension Dosage Forms https://www.sawai.co.jp/en/file/2018/10/20181024-03.pdf Wed, 24 Oct 2018 14:51:27 +0000 Sawai Pharmaceutical Receives Public Knowledge-Based Applications for Anti-Cancer Agent OXALIPLATIN I.V. Infusion Solution for Additional Indication https://www.sawai.co.jp/en/file/2018/09/20180921-02.pdf Fri, 21 Sep 2018 13:10:02 +0000 MHLW Approves New Indication for ARIPIPRAZOLE Tablets 3 mg / 6 mg / 12 mg / 24mg [SAWAI] and ARIPIPRAZOLE Oral Solution 3 mg / 6 mg / 12 mg Packet [SAWAI] https://www.sawai.co.jp/en/file/2018/09/20180905-02.pdf Wed, 05 Sep 2018 15:06:44 +0000 Upsher-Smith Launches Generic Version of Lomotil® (Diphenoxylate Hydrochloride and Atropine Sulfate) Tablets https://www.sawai.co.jp/en/file/2018/09/20180903-02.pdf Mon, 03 Sep 2018 10:22:50 +0000 Sawai Pharmaceutical Receives Approvals for Six Compounds with 13 Strengths of Generic Drugs https://www.sawai.co.jp/en/file/2018/08/20180816-02.pdf Thu, 16 Aug 2018 15:30:37 +0000 IR “Summary of Financial Results for the 1st Quarter of FY2018” https://www.sawai.co.jphttp://v4.eir-parts.net/v4Contents/View.aspx?template=ir_material_for_fiscal_ym&sid=51863&code=4555 Tue, 14 Aug 2018 15:07:05 +0000 IR “Financial Results for the 1st Quarter of FY2018” https://www.sawai.co.jphttp://v4.eir-parts.net/v4Contents/View.aspx?template=ir_material_for_fiscal_ym&sid=51862&code=4555 Tue, 14 Aug 2018 15:06:27 +0000 Upsher-Smith Launches Bexarotene Capsules https://www.sawai.co.jp/en/file/2018/08/20180808-02.pdf Wed, 08 Aug 2018 15:08:18 +0000 Upsher-Smith Launches Vigabatrin for Oral Solution Under the Brand Name Vigadrone™ https://www.sawai.co.jp/en/file/2018/07/20180717-02.pdf Tue, 17 Jul 2018 15:33:00 +0000 Announcement on Completion of Transfer of Manufacturing and Marketing Approval of Zomig® Tablets 2.5 mg and Zomig® RM Tablets 2.5 mg, Migraine Treatment https://www.sawai.co.jp/en/file/2018/06/20180620-03.pdf Wed, 20 Jun 2018 10:59:46 +0000 Sawai Pharmaceutical Launches 7 Compounds with 17 Strengths of Generic Drugs https://www.sawai.co.jp/en/file/2018/06/20180614-02.pdf Thu, 14 Jun 2018 17:00:32 +0000 MHLW approves New Indication for OSELTAMIVIR Capsules 75mg [SAWAI] / Dry Syrup 3% [SAWAI] https://www.sawai.co.jp/en/file/2018/06/20180606-02.pdf Wed, 06 Jun 2018 15:00:51 +0000 Sawai Pharmaceutical Submits Public Knowledge-Based Application for Anti-Cancer Agent OXALIPLATIN I.V. Infusion Solution for Additional Indication https://www.sawai.co.jp/en/file/2018/05/20180525-02.pdf Fri, 25 May 2018 18:00:05 +0000 IR “Medium-Term Business Plan (M1 TRUST 2021)” https://www.sawai.co.jphttp://v4.eir-parts.net/v4Contents/View.aspx?template=ir_material&sid=92369&code=4555 Tue, 15 May 2018 15:03:04 +0000 IR “Summary of Financial Results for FY 2017” https://www.sawai.co.jphttp://v4.eir-parts.net/v4Contents/View.aspx?template=ir_material_for_fiscal_ym&sid=48369&code=4555 Tue, 15 May 2018 15:02:07 +0000 IR “Financial Results for FY 2017” https://www.sawai.co.jphttp://v4.eir-parts.net/v4Contents/View.aspx?template=ir_material_for_fiscal_ym&sid=48372&code=4555 Tue, 15 May 2018 15:01:33 +0000